Genmab A/S (GMAB)
55.08
-0.44
(-0.79%)
USD |
NASDAQ |
Nov 04, 16:00
55.08
0.00 (0.00%)
After-Hours: 18:01
Genmab Total Return Price : 55.08 for Nov. 4, 2026
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| November 03, 2026 | 55.52 |
| November 02, 2026 | 54.92 |
| October 30, 2026 | 57.06 |
| October 29, 2026 | 56.49 |
| October 28, 2026 | 57.29 |
| October 27, 2026 | 44.67 |
| October 26, 2026 | 44.68 |
| October 23, 2026 | 43.79 |
| October 22, 2026 | 40.00 |
| October 21, 2026 | 39.57 |
| October 20, 2026 | 39.07 |
| October 19, 2026 | 38.50 |
| October 16, 2026 | 37.00 |
| October 15, 2026 | 37.82 |
| October 14, 2026 | 36.89 |
| October 13, 2026 | 36.57 |
| October 12, 2026 | 37.37 |
| October 09, 2026 | 37.07 |
| October 08, 2026 | 36.05 |
| October 07, 2026 | 36.65 |
| October 06, 2026 | 37.80 |
| October 05, 2026 | 38.48 |
| October 02, 2026 | 34.75 |
| October 01, 2026 | 34.55 |
| September 30, 2026 | 35.68 |
| Date | Value |
|---|---|
| September 29, 2026 | 35.57 |
| September 28, 2026 | 35.36 |
| September 25, 2026 | 35.32 |
| September 24, 2026 | 34.83 |
| September 23, 2026 | 34.75 |
| September 22, 2026 | 35.22 |
| September 21, 2026 | 34.69 |
| September 18, 2026 | 34.74 |
| September 17, 2026 | 34.54 |
| September 16, 2026 | 34.40 |
| September 15, 2026 | 34.15 |
| September 14, 2026 | 32.65 |
| September 11, 2026 | 32.47 |
| September 10, 2026 | 32.23 |
| September 09, 2026 | 33.04 |
| September 08, 2026 | 33.53 |
| September 04, 2026 | 33.60 |
| September 03, 2026 | 34.41 |
| September 02, 2026 | 34.22 |
| September 01, 2026 | 33.29 |
| August 31, 2026 | 33.16 |
| August 28, 2026 | 33.23 |
| August 27, 2026 | 34.10 |
| August 26, 2026 | 33.75 |
| August 25, 2026 | 34.36 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| AbbVie, Inc. | 294.77 |
| Incyte Corp. | 122.91 |
| Ascendis Pharma A/S | 258.06 |
| Zealand Pharma A/S | 34.63 |
| Novo Nordisk A/S | 42.17 |